Replies to post #65217 on NanoViricides Inc. (NNVC)

[Echo20]

JG36
JG36

OK:

5000 animal tests on:

Flucide
Flucide multi-clade
Flucide Super
FLucide intravenius
Flucide Oral
Flucide for HXNX (all FLus)

Denguecide
Denguecide at Dr Harris and Berkely

Herpescide at TheVac at LSU and Feindstein University

Herpescide at NOUCM and Dr Rosenthal

HIVcide
Drugs Currently in Pre-clinical testing:
1. FluCide antiviral against HxNx (H1N1 Swine Flu, H5N1 Avi Flu, etc)
2. Dengue Antiviral (UC Berkeley, Dr. Eva Harris)
3. HIV-Cide (UCSF)
4. EKC/Eye Herpes (Thevac, Feinstein Institute)
5. HSV-1 and HSV-2 antiviral (NOUCM, Dr Ken S. Rosenthal)
6. EbolaCide for Ebola (USAMRIID)
Getting ready for the IND for FLUCIDE and the FDA.
Meeting requirements set by the US FDA at the PRE-IND Meeting.
Getting out 100 patents for Flucide in as many countries. (ahead of time)

Each animal test costs money.

Getting ready for Phase One clinical tests on humans in Austrailia.

These are each important steps.

Each of these take time and money.

The investors in NNVC are really and actually forwarding medical progress.

Echo 20